NCT07043478

A Clinical Trial to Investigate the Efficacy of Bragg Apple Cider Vinegar on Blood Glucose Control in a Healthy Adult Population

A Randomized, Single-blind, Controlled, Cross-over Clinical Trial to Investigate the Efficacy of Bragg Apple Cider Vinegar on Blood Glucose Control in a Healthy Adult Population

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Bragg Live Food Products · Industry
• Sex: All
• Age: 20 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical study is to investigate the efficacy of a Bragg Apple Cider Vinegar (ACV) liquid on postprandial glucose (PPG) excursion compared to a placebo following a standardized acute carbohydrate load. The main question it aims to answer is: Is there a difference in the incremental area under the curve (iAUC) (from 0 - 120 mins following administration) for venous blood glucose between Bragg ACV liquid and placebo following an acute carbohydrate load. Participants will \[describe the main tasks participants will be asked to consume 750 mg of Bragg Apple Cider Vinegar (ACV) liquid or water and undergo a blood draw to measure glucose, insulin, and future analysis markers.

Conditions

• Healthy
• Blood Glucose

Interventions

Type	Name	Description
OTHER	Bragg ACV Liquid	Apple Cider Vinegar
OTHER	Placebo	Water

Timeline

• Start date: 2025-08-05
• Primary completion: 2026-03-01
• Completion: 2026-03-01
• First posted: 2025-06-29
• Last updated: 2026-03-06

Locations

1 site across 1 country: Canada